loading

Cognition Therapeutics Inc Azioni (CGTX) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - -
Operating Expenses
1.47%
13.98
13.78 10.72 14.46 14.68
Operating Income/Loss
1.47%
-13.98
-13.78 -10.72 -14.46 -14.68
Income/Loss From Continuing Operations Before Tax
20.59%
-6.734
-8.48 -7.842 -9.937 -7.041
Income/Loss From Continuing Operations After Tax
20.59%
-6.734
-8.48 -7.842 -9.937 -7.041
Net Income/Loss
20.59%
-6.734
-8.48 -7.842 -9.937 -7.041
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
3.01%
63.69
61.83 1.6495 40.42 40.06
Diluted Average Shares
3.01%
63.69
61.83 1.6495 40.42 40.06
Basic Earnings Per Share
21.43%
-0.11
-0.14 -0.17 -0.25 -0.18
Diluted Earnings Per Share
21.43%
-0.11
-0.14 -0.17 -0.25 -0.18
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$35.54
price down icon 0.28%
$83.24
price down icon 1.06%
$29.29
price down icon 0.58%
$98.88
price down icon 0.70%
$139.87
price down icon 0.96%
biotechnology ONC
$331.52
price up icon 0.51%
Capitalizzazione:     |  Volume (24 ore):